Utah Attorney General joins 23andMe lawsuit objecting sale of private genetic data
SALT LAKE CITY () — The Utah Attorney General has joined other states in filing a lawsuit that could prevent 23andMe from selling their genetic data following bankruptcy earlier this year.
Utah Attorney General Derek Brown has joined a 'bipartisan coalition' of 27 attorneys general in filing a lawsuit against 23andMe, according to a press release from the Utah Attorney General's Office. According to the lawsuit, the company has collected Genotype Data from roughly 15 million people.
Earlier this year, in March, , and their CEO stepped down. The company went up for sale, causing many about private data that was maintained by the genetic profiling company.
The Utah Attorney General's Office recommended that Utahns before the sale. It reminded Utahns of their rights under the Utah Consumer Privacy and the Genetic Information Privacy Acts.
How to protect (and delete) your DNA data after 23andMe bankruptcy filing
The goal of this lawsuit is to 'prevent the company from selling Utahns' private genetic information to another company without their express consent,' the press release states. The company is reportedly planning to sell the genetic information it gathered through home DNA collection kits.
'Utahns entrusted 23andMe with their most personal genetic information, under the promise of privacy and protection. The company's intent to sell this data to the highest bidder is an egregious betrayal of that trust and will not be tolerated,' Katie Hass, Director of the Utah Division of Consumer Protection, is quoted in the release. 'Every consumer should have the right to decide how this intimate, personal, and unique data is handled going forward.'
The lawsuit argues that genetic information is 'immutable,' meaning that if it is 'stolen or misused, it cannot be replaced.' Consumers who have their genetic data used by a company they do not trust have no way to protect themselves or change that information.
'The States respectfully request that the Court (a) enter a declaratory judgment as to the issues set forth… prior to any sale; (b) and enter any further relief to which the Court finds is just,' the lawsuit concludes.
The other attorneys general joining the lawsuit are from the following states: Arizona, Colorado, Connecticut, the District of Columbia, Florida, Illinois, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Missouri, New Hampshire, New Mexico, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
Farmington Bay volunteer honored with 'Birder of the Year' nomination after more than 20 years of service
Utah Attorney General joins 23andMe lawsuit objecting sale of private genetic data
Mountain View Corridor closing to all pass-through traffic for five weeks
BMW's new flagship SUV to debut in US
Los Angeles-area mayors demand that Trump administration stop stepped-up immigration raids
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 days ago
- Yahoo
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision Biologics, Danaher Corporation (Cepheid Inc.), GE HealthCare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., Biogen, QIAGEN, Genentech Inc., 23andMe Inc., Asuragen Inc and others. Austin, TX, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'US Personalized Medicine Market Size, Trends and Insights By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Nutrition and Wellness), By Application (Oncology, CNS, Immunology, Respiratory, Liver, Rheumatology), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Genetics, Liquid Biopsy, Others (Predictive Modeling, Imaging)), By End-user (Hospitals, Diagnostic Centers, Research & Academic Institutes), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034' in its research database.'According to the latest research study, the demand of US Personalized Medicine Market size & share was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach a value of around USD 252.93 Billion by 2034, at a compound annual growth rate (CAGR) of about 17.32% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the US Personalized Medicine Market @ Overview As per the industry experts at CMI, the U.S. personalized medicine market is poised to witness a whopping CAGR in the forecast period. This could be attributed to genomic advancements such as next-generation sequencing that facilitate more accurate diagnostics and targeted therapies. The patients are asking for more customized approaches toward healthcare, thereby resulting in higher adoption of personalized medicine. Rise in incidences of chronic diseases such as cardiovascular diseases, cancer, and diabetes is accelerating the requirement of more personalized and effective treatment strategies. Conducive government policies coupled with raised funding for research and development activities are driving innovation. Key Trends & Drivers Technological Advancements and Higher Healthcare Spending to Spell Growth: Continuous advancements in data analytics, genomics, and bioinformatics are pushing the U.S. personalized medicine market forward. technologies such as CRISPR, NGS, and AI are transformingtreatment plans and diagnostics and making them more targeted as well as individualized. This innovation translates into patients' better understanding and customizes the treatment with better results. Also, as healthcare spending increases, the government as well as private agencies continue spending more dollars on the new technologies pertaining to modern medicine as mentioned above. Request a Customized Copy of the US Personalized Medicine Market Report @ Rise in Incidences of Chronic Diseases to Catalyze the U.S. Personalized Medicine Market: Chronic ailments cover conditions such as diabetes, cancer, and cardiovascular ailments. Personalized medicines are capable of being more effective in comparison with conventional types of treatment as they end up targeting the molecular and genetic basis of the conditions they address. Report Scope Feature of the Report Details Market Size in 2025 USD 66.13 Billion Projected Market Size in 2034 USD 252.93 Billion Market Size in 2024 USD 56.37 Billion CAGR Growth Rate 17.32% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Product, Application, Technology, End-user and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Country Scope US Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the US Personalized Medicine report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the US Personalized Medicine report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the US Personalized Medicine Market Report @ SWOT Analysis Strengths: Genomic medicine is getting included in clinical practice. It is playing a vital role in diagnosing as well as treating the disease, thereby offering precise, individualized treatments providing better outcomes. Also, institutions are sharing data concerning clinical background, genetic information, and lifestyles across the providers, which facilitates the provision of more extensive and individualized treatment options, thereby helping to release new drugs in a faster way. Weaknesses: Tailored treatments such as sequencing, genetic tests, and targeted medications are costlier in comparison with conventional treatments. This factor does act as a substantial barrier to healthcare systems and insurance firms. Also, handling sensitive data does raise legal and ethical challenges pertaining to data privacy and security. These are some of the threats to the U.S. personalized medicine market. Opportunities: Amalgamating personalized medicine with digital health technologies such as remote monitoring and wearable devices is anticipated to improve patient engagement as well as treatment outcomes. Personalized medicine can also help in the identification of disease risks and promotion of preventive measures. Strategic partnerships amongst research organizations, academic institutions, and industry players have the ability to accelerate the adoption and development of personalized medicine. Threats: Lengthy processes of approvals and complicated regulatory requirements for personalized medicine products are likely to delay market access. The market players are bound to lose interest by the time the entire course of treatment or drugs gets approved and goes live. These are the major threats to the U.S. personalized medicine market. Request a Customized Copy of the US Personalized Medicine Market Report @ Key questions answered in this report: What is the size of the US Personalized Medicine market and what is its expected growth rate? What are the primary driving factors that push the US Personalized Medicine market forward? What are the US Personalized Medicine Industry's top companies? What are the different categories that the US Personalized Medicine Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the US Personalized Medicine market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium US Personalized Medicine Research Report | Fast Delivery Available - [220+ Pages] @ Key Developments The US personalized medicine market is witnessing a significant organic and inorganic expansion. Some of the key developments include – In May 2025, the scientists based in Philadelphia officiated a successful treatment for one of the rare genetic disorders in a nine-month-old baby using personalized CRISPR gene editing therapy. In January 2024, The US state of California announced that it would witness establishment of precision medicine center as the outcome of collaboration amongst the city of Bakersfield, the Kern Venture Group, and BIOS Health. The facility is bound to operate as a central location for R&D and brain clinical trials that use BIOS' adaptive dosage technology. In March 2023, Seagen announced that Pfizer acquired it for USD 229 in cash per Seagen share, totaling to USD 43 Billion enterprise value. Request a Customized Copy of the US Personalized Medicine Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? Email Directly Here with Detail Information: support@ Browse the full 'US Personalized Medicine Market Size, Trends and Insights By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Nutrition and Wellness), By Application (Oncology, CNS, Immunology, Respiratory, Liver, Rheumatology), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Genetics, Liquid Biopsy, Others (Predictive Modeling, Imaging)), By End-user (Hospitals, Diagnostic Centers, Research & Academic Institutes), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034' Report at of the prominent players in the US Personalized Medicine Market: Illumina Inc. Precision Biologics Danaher Corporation (Cepheid Inc.) GE HealthCare Celera Diagnostics LLC Decode Genetics Inc. Exact Sciences Corporation IBM Corporation Exagen Inc. Biogen QIAGEN Genentech Inc. 23andMe Inc. Asuragen Inc. Others Click Here to Access a Free Sample Report of the US Personalized Medicine Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. Personalized market brief by author. Browse More Related Reports: Induced Pluripotent Stem Cell (iPSC) Market: Induced Pluripotent Stem Cell (iPSC) Market Size, Trends and Insights By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others), By Application (Drug Development, Tissue Engineering & Regenerative Medicine, Disease Modelling, Toxicology Research), By End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Fabry Disease Treatment Market: Fabry Disease Treatment Market Size, Trends and Insights By Treatment (Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate Reduction Therapy (SRT), Others), By Route of Administration (Intravenous Route, Oral Route), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Elastomeric Infusions Pumps Market: Elastomeric Infusions Pumps Market Size, Trends and Insights By Product (Variable Rate, Continuous Rate), By Application (Antibiotic/Antiviral Therapy, Chemotherapy, Pain Management, Others), By End-Use (Ambulatory Surgical Centers, Hospitals, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Duchenne Muscular Dystrophy Drugs Market: Duchenne Muscular Dystrophy Drugs Market Size, Trends and Insights By Drug Type (Exon skipping drugs, Corticosteroids, Gene therapy, Other drug types), By Route of Administration (Oral, Injectable), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Digital Microscopes Market: Digital Microscopes Market Size, Trends and Insights By Product Type (Digital Biological Microscopes, Electron Microscope, Digital Surgical Microscopes, Others (Digital Inspection Camera, and Others)), By Modality (Desktop Digital Microscope, Portable Digital Microscope), By Connectivity (Wired Digital Microscope, Wireless Digital Microscope), By Application (Research & Development, Life Science, Medical Diagnostics, Forensic Testing), By End User (Hospitals, Clinics, Biopharmaceutical Companies, Academic Research Institute, Others (Forensic and Pathology Laboratory)), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Adult Day Care Services Market: Adult Day Care Services Market Size, Trends and Insights By Services (Adult Social Day Services, Adult Day Healthcare Services, Specialized Day Care Services), By Service Provider (Private, Public), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Synthetic Blood Substitutes and Blood Product Market: Synthetic Blood Substitutes and Blood Product Market Size, Trends and Insights By Source (Human Blood, Animal Blood, Synthetic Polymers, Stem Cells, Others), By Type (Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander), By Installation Type (Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Others), By End-User (Hospitals and Clinics, Blood Banks, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Dental Prosthetics Market: Dental Prosthetics Market Size, Trends and Insights By Type (Crowns, Bridges, Abutments, Dentures, Others), By End-User (Solo Practices, DSO/Group Practices, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 The US Personalized Medicine Market is segmented as follows: By Product Personalized Medicine Diagnostics Personalized Medicine Therapeutics Personalized Nutrition and Wellness By Application Oncology CNS Immunology Respiratory Liver Rheumatology By Technology Big Data Analytics Artificial Intelligence Bioinformatics Gene Sequencing Drug Discovery Companion Diagnostics Genetics Liquid Biopsy Others (Predictive Modeling, Imaging) By End-user Hospitals Diagnostic Centers Research & Academic Institutes Click Here to Get a Free Sample Report of the US Personalized Medicine Market @ This US Personalized Medicine Market Research/Analysis Report Contains Answers to the following Questions. Which Trends Are Causing These Developments? Who Are the Key Players in This US Personalized Medicine Market? What are Their Company Profile, Product Information, and Contact Information? What Was the Market Status of the US Personalized Medicine Market? What Was the Capacity, Production Value, Cost and PROFIT of the US Personalized Medicine Market? What Is the Current Market Status of the US Personalized Medicine Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of US Personalized Medicine Market by Considering Applications and Types? What Are Projections of the US Personalized Medicine Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is US Personalized Medicine Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On US Personalized Medicine Industry? What are Macroeconomic Environment Analysis Results? What Are Macroeconomic Environment Development Trends? What Are Market Dynamics of US Personalized Medicine Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for US Personalized Medicine Industry? Click Here to Access a Free Sample Report of the US Personalized Medicine Market @ Reasons to Purchase US Personalized Medicine Market Report US Personalized Medicine Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. US Personalized Medicine Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. US Personalized Medicine Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. US Personalized Medicine Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the US Personalized Medicine market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established key players fuel market growth. Buy this Premium US Personalized Medicine Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide US Personalized Medicine market analysis. The competitive environment of current and potential participants in the US Personalized Medicine market is covered in the report, as well as those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions. For each segment mentioned above, actual market sizes and forecasts have been given. Who should buy this report? Participants and stakeholders worldwide US Personalized Medicine market should find this report useful. The research will be useful to all market participants in the US Personalized Medicine industry. Managers in the US Personalized Medicine sector are interested in publishing up-to-date and projected data about the worldwide US Personalized Medicine market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in US Personalized Medicine products' market trends. Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. Request a Customized Copy of the US Personalized Medicine Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium US Personalized Medicine Research Report | Fast Delivery Available - [220+ Pages] @ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Newsweek
12-08-2025
- Newsweek
Property Tax Change To Affect 800,000 Americans
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Almost 800,000 homeowners in Utah are set to face higher property tax bills as a result of an 11.11 percent increase voted for by the Jordan Valley Water Conservancy District board on Monday. The tax increase, which the board said would help the company stay afloat in the coming years, is estimated to add more than $12 a year for the average homeowner in Salt Lake County and $21 a year for businesses. It is a relatively small sum, but it comes on top of years of property tax increases for homeowners across the U.S. Between 2019 and 2024, nationwide property taxes surged by almost 30 percent, according to Redfin, reaching a yearly median of $3,500. In Utah, where the effective tax rate is 0.46 percent and the average home value is $530,250, according to Bankrate, the average property tax on a typical home is $2,439 a year. But the increase is about more than higher housing costs. Local activists say the tax increase will make Utah's municipal water even cheaper than it is now, exacerbating the issue of water waste in the drought-prone state and accelerating the collapse of the Great Salt Lake. Newsweek contacted the Jordan Valley Water Conservancy District board and Utah Rivers Council for comment by email on Tuesday. Why Are Utah Homeowners Facing an Increase? The Jordan Valley Water Conservancy District board—one of the largest water districts in the state—said that higher revenues would allow it to strengthen its footing in the next five years and implement much-needed changes. This has to do with the way Utah charges residents for their water use. While Utahns receive a monthly water bill, a significant part of their consumption is paid for through homeowners' and businesses' property taxes. Jordan Valley said the increase in property taxes would not only allow it to keep the cost of water low but also to maintain and build infrastructure vital to keeping taps running in the state. A "Welcome to Utah" sign near Glen Canyon National Recreation Area in Page, Arizona, on July 10. A "Welcome to Utah" sign near Glen Canyon National Recreation Area in Page, Arizona, on July 10."The benefit of it is having a strong financial ability for Jordan Valley because we're growing and building new facilities for future generations," Alan Packard, the general manager of the Water Conservancy District, said in a statement reported by ABC4. "It's important we have good credit rating and having some of our revenue come from a reliable source like property taxes helps that credit rating and lowers our interest cost we pay when we issue bonds," he added. According to Packard, higher revenues from property tax bills will allow the district to do things like "expanding out water treatment plants and building major new aqueducts." Higher property taxes would allow the company to "manage a loss of revenue of $3.1 million not only this year but each year into the future because that's how much revenue will be generated annually and going forward," Packard said. What Do Local Residents Think? Many Utahns have voiced strong opposition to the property tax increase in the lead-up to its approval on Monday, and not only because it adds to the financial burden carried by many homeowners already struggling with higher housing costs. According to Utah Rivers Council, a nonprofit protecting the state's watersheds, property taxes in Utah are used to subsidize municipal water—making it so cheap "that Utahns aren't incentivized to save it, which is why we constantly see sprinklers watering sidewalks and gutters," the group wrote on Facebook. Stats shared by the group show that the average Utah city consumes 245 gallons of municipal water per capita per day, compared to the U.S. average of 138—placing locals among the more wasteful water users in the country. For the Utah Rivers Council, the state's property tax should be written off entirely, and the system changed so that residents pay the price of the water they consume. Some tax experts and local homeowners are of the same opinion. Stephen Kenyon, a longtime Utah resident living on a fixed income with his wife, Julie, told KUTV: "We get nothing out of this. We don't get any part of any increase—just an increase in taxes. We would like to see those in charge look at where you can cut and do better." In July, The Salt Lake Tribune published an editorial calling for Utah to "stop using property taxes to hide the cost of water" and to change the taxing system to charge for every gallon of water consumed in the state. Criticism against Utah's property tax system is growing, and it has clearly reached the Jordan Valley Water Conservancy District board itself—even if the hike ultimately slipped through. Two board members of Jordan Valley were against Monday's increase. "Before we, as government, go and ask them for more taxes, we need to do everything possible to cut costs and tighten our belts," Riverton City Council Member Andy Pierucci, one of the two dissenting votes on the Jordan Valley Water Conservancy District board, told KUTV. He added, "I don't feel like we've done that enough yet."
Axios
08-08-2025
- Axios
Report: Tariffs could drive up Utah car insurance rates by year's end
Car insurance rates in Utah could rise more by the end of the year thanks to tariffs, a new projection finds. Why it matters: The analysis illustrates just one more way Americans pay for higher tariffs. Driving the news: The nationwide average annual cost of full-coverage car insurance could rise 7% between June and December if tariffs stay in effect, compared to 4% otherwise, per a new report from insurance-comparison platform Insurify. In raw terms, the average cost could hit $2,472 with tariffs, compared to $2,402 without them. For Utahns, rates are expected to climb about 7.6% with tariffs to $2,006 or 4.6% to $1,950 without. Between the lines: That's based on the tariff picture as of Aug. 1, reflecting the Trump administration's recently lowered rates on cars and auto parts from Japan, South Korea and Europe. By the numbers: Utahns typically pay about $1,978 for full coverage auto insurance annually, or nearly $165 a month, which is about 17% lower than the national average. Between the lines: Tariffs affect insurance rates by increasing the costs of imported parts needed for repairs. Inflation, accident frequency, and claims due to extreme weather also impact rates, among other factors. What they're saying: "Initially, car insurance companies looked at 2025 as a year to keep insurance rates stable, or even cut them," per Insurify's report. Claims volume could also fall, and insurance regulators could fight price hikes.
